Skip to content

Epidemiological Study on Anemia and Iron Deficiency in Pregnancy in Medical Institutions in Some Areas of China

Epidemiological Study on Anemia and Iron Deficiency in Pregnancy in Medical Institutions in Some Areas of China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04486456
Enrollment
20000
Registered
2020-07-24
Start date
2020-08-31
Completion date
2022-12-31
Last updated
2020-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevalence

Keywords

Iron deficiency, Anemia during pregnancy

Brief summary

The purpose of this study is to describe the prevalence of anemia and iron deficiency in pregnancy through a multi-center, prospective follow-up study . To explore the influence factors of anemia and iron deficiency in pregnancy; to explore the influence of anemia and iron deficiency in pregnancy on maternal and fetal outcomes.

Detailed description

1. To understand the epidemiological characteristics of anemia and iron deficiency in pregnancy and describe the epidemiological situation of anemia and iron deficiency. 2. To explore the influence factors of anemia and iron deficiency in pregnancy. 3. To explore the influence of anemia and iron deficiency during pregnancy on the pregnancy outcome of mothers and infants.

Interventions

None listed

Sponsors

Peking University First Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

* Regular prenatal check-ups were conducted in the hospitals participating in the study, and pregnant women who planned to give birth in hospital were established a maternity health manual * 18 years and older * Patients have to agree to participate by signing a consent

Exclusion criteria

* have severe chronic diseases with Pre-pregnancy * Suffer from severe mental illness

Design outcomes

Primary

MeasureTime frameDescription
HbCompleted by observation,an average of 1 yearProportion of patients with Hb\<110g/L

Secondary

MeasureTime frameDescription
SFCompleted by observation,an average of 1 yearProportion of patients with SF\<20μg/L

Contacts

Primary ContactSong X Zhang
1033341681@qq.com13901024399

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026